Drug major Ranbaxy has said it has received approval from the Australian health regulator to market its antipsychotic drug Ozidal Risperidone in that country. Ranbaxy Australia, the wholly-owned subsidiary of the company, has received an approval from the Therapeutic Goods ... Read More »